Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction
Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction have?
Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction published?
Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction has 2025 year in the ScholarIQ index.
What is the open-access status of Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction?
Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction has closed oa status in the ScholarIQ index.
What is the DOI of Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction?
The DOI for Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction is on the source record.
What is the OpenAlex record for Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction?
The OpenAlex for Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction is on the source record.